Spinal Tech

ArthroCAD completed Series A round of financing to secure funds for its total hip arthroplasty product development.

Hydrocision hopes to spread the word about the effectiveness of its minimally invasive treatment for herniated disc pain, according to the Boston Business Journal.

The FDA announced 510(k) clearance of two spine surgery devices from VertiFlex, the Totalis Direct Decompression System and the UniVise Spinous Process Fixation System.

Medical device manufacturer Zimmer plans to close its Austin, Texas, facility by the end of July in an effort to streamline business, according to Mass Device.

Rebound Orthopedics & Neurosurgery, based in Vancouver, has received a $265,000 grant from MAKO Surgical, according to a Vancouver Business Journal report.

Cleveland-based AxioMed Spine has garnered $3.6 million in capital funding for development of its degenerative spine products, according to Med City News.

Stryker has increased the low-end estimate for its hip implant recall, now saying it will cost between $190 million and $390 million for the testing, lawsuits and insurance payments, according to Claims Journal.

AxoGen will present the results of the clinical studies for the Avance Nerve Graft at the American Association for Hand Surgery annual meeting.

GE Capital will serve as the administrator of a $21.5 million investment into Amedica's spine device product development and growth.

The Food and Drug Administration granted 38 orthopedic- and spine-related device clearances in December.